A Study to Evaluate the Safety and Diagnostic Performance of F18 FBPA PET/CT Imaging in Solid Tumors
18h agoen
From the article
Conditions : Solid Tumor Interventions : Drug: F18 FBPA Injection Sponsors : Heron Neutron Medical Corp. Recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Experimental Novartis radiopharma drug shows promise in early study
reuters.com·1mo ago
GE HealthCare and Mayo Clinic launch theranostics study to personalize prostate cancer treatment
GE HealthCare and Mayo Clinic have launched the MI-BET research collaboration, a theranostics study aimed at developing a more personalized
mayocl.in·1d ago
Development of LRRC15-binding disulfide-constrained peptides for PET imaging of cancer-associated fibroblasts
doi.org·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.